Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese
- PMID: 21304814
- PMCID: PMC3033414
- DOI: 10.1371/journal.pone.0016748
Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese
Abstract
Background: Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5, also called as survivin) is a member of the inhibitor of apoptosis protein (IAP) family, which plays an important role in the occurrence and progression of cancer. Recently, a polymorphism in the promoter of BIRC5, -31C/G (rs9904341), was shown to influence BIRC5 expression.
Methods: We examined whether the -31C/G was related to the risk of developing nasopharyngeal carcinoma (NPC) in a case-control population from Guangxi province in southern China, which consists of 855 patients with NPC and 1036 controls. This polymorphism was genotyped by TaqMan assay. The genetic associations with the occurrence and progression of NPC were estimated by logistic regression.
Results: We observed a statistically significant increased occurrence of NPC associated with the CC genotype (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.13-1.73; P=0.0020) compared with the genotypes containing G allele (CG + GG genotype). However, no significant association was observed for the -31C/G with the severity of NPC (as measured by tumor-node-metastasis staging system).
Conclusion: Our findings suggest that the functional polymorphism -31C/G in the promoter of BIRC5 gene may play a role in mediating the susceptibility to NPC among Chinese.
Conflict of interest statement
Similar articles
-
Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.BMC Cancer. 2013 Jul 24;13:356. doi: 10.1186/1471-2407-13-356. BMC Cancer. 2013. PMID: 23883402 Free PMC article.
-
Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.PLoS One. 2012;7(1):e28829. doi: 10.1371/journal.pone.0028829. Epub 2012 Jan 25. PLoS One. 2012. PMID: 22295057 Free PMC article.
-
MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.Clin Cancer Res. 2007 May 1;13(9):2627-33. doi: 10.1158/1078-0432.CCR-06-2281. Clin Cancer Res. 2007. PMID: 17473193
-
A functional polymorphism in MIR196A2 is associated with risk and progression of nasopharyngeal carcinoma in the Chinese population.Genet Test Mol Biomarkers. 2014 Mar;18(3):149-55. doi: 10.1089/gtmb.2013.0400. Epub 2013 Dec 13. Genet Test Mol Biomarkers. 2014. PMID: 24328526
-
Nasopharyngeal carcinoma in the Northeastern states of India.Chin J Cancer. 2011 Feb;30(2):106-13. doi: 10.5732/cjc.010.10607. Chin J Cancer. 2011. PMID: 21272442 Free PMC article. Review.
Cited by
-
BIRC5 Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas.Int J Mol Sci. 2023 Dec 14;24(24):17490. doi: 10.3390/ijms242417490. Int J Mol Sci. 2023. PMID: 38139318 Free PMC article.
-
Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer.Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1289-1293. doi: 10.31557/APJCP.2019.20.4.1289. Asian Pac J Cancer Prev. 2019. PMID: 31031231 Free PMC article.
-
Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development.World J Oncol. 2015 Feb;6(1):243-261. doi: 10.14740/wjon610w. Epub 2015 Feb 14. World J Oncol. 2015. PMID: 29147412 Free PMC article. Review.
-
Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.BMC Cancer. 2013 Jul 24;13:356. doi: 10.1186/1471-2407-13-356. BMC Cancer. 2013. PMID: 23883402 Free PMC article.
-
Cigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studies.BMJ Open. 2017 Oct 5;7(10):e016582. doi: 10.1136/bmjopen-2017-016582. BMJ Open. 2017. PMID: 28982817 Free PMC article.
References
-
- Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365:2041–2054. - PubMed
-
- Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1765–1777. - PubMed
-
- Zhou G, Zhai Y, Cui Y, Qiu W, Yang H, et al. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Hum Mutat. 2007;28:1091–1097. - PubMed
-
- Zhou G, Zhai Y, Cui Y, Zhang X, Dong X, et al. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res. 2007;13:2627–2633. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials